173 related articles for article (PubMed ID: 30151272)
1. Is there an optimal staging system or liver reserve model that can predict outcome in hepatocellular carcinoma?
Jaruvongvanich V; Sempokuya T; Wong L
J Gastrointest Oncol; 2018 Aug; 9(4):750-761. PubMed ID: 30151272
[TBL] [Abstract][Full Text] [Related]
2. ALBI and PALBI grade predict survival for HCC across treatment modalities and BCLC stages in the MELD Era.
Liu PH; Hsu CY; Hsia CY; Lee YH; Chiou YY; Huang YH; Lee FY; Lin HC; Hou MC; Huo TI
J Gastroenterol Hepatol; 2017 Apr; 32(4):879-886. PubMed ID: 27696519
[TBL] [Abstract][Full Text] [Related]
3. Albumin-Bilirubin and Platelet-Albumin-Bilirubin Grades Accurately Predict Overall Survival in High-Risk Patients Undergoing Conventional Transarterial Chemoembolization for Hepatocellular Carcinoma.
Hansmann J; Evers MJ; Bui JT; Lokken RP; Lipnik AJ; Gaba RC; Ray CE
J Vasc Interv Radiol; 2017 Sep; 28(9):1224-1231.e2. PubMed ID: 28688815
[TBL] [Abstract][Full Text] [Related]
4. Albumin-bilirubin index and platelet-albumin-bilirubin index contribute to identifying survival benefit candidates in patients with hepatocellular carcinoma and Child-Pugh grade A undergoing transcatheter arterial chemoembolization with sorafenib treatment.
Hu K; Yuan J; Tang B; Zhang F; Lu S; Chen R; Zhang L; Ren Z; Yin X
Ann Transl Med; 2021 Feb; 9(3):237. PubMed ID: 33708864
[TBL] [Abstract][Full Text] [Related]
5. Albumin-bilirubin and platelet-albumin-bilirubin grades for hepatitis B-associated hepatocellular carcinoma in Child-Pugh A patients treated with radical surgery: A retrospective observational study.
Wu B; Hu X; Jin H; Zhou L; Zhang D; Man Z; Wang Y; Yang S; Pang Q; Liu H; Cui P
Medicine (Baltimore); 2019 Oct; 98(43):e17394. PubMed ID: 31651841
[TBL] [Abstract][Full Text] [Related]
6. Comparing various scoring system for predicting overall survival according to treatment modalities in hepatocellular carcinoma focused on Platelet-albumin-bilirubin (PALBI) and albumin-bilirubin (ALBI) grade: A nationwide cohort study.
Lee SK; Song MJ; Kim SH; Park M
PLoS One; 2019; 14(5):e0216173. PubMed ID: 31048923
[TBL] [Abstract][Full Text] [Related]
7. The Significance of Platelet-Albumin-Bilirubin (PALBI) Grade in Hepatocellular Carcinoma Patients Stratified According to Platelet Count.
Pang Q; Liu S; Wang L; Pan H; Wang C; Zhou L; Lu Y; Liu H
Cancer Manag Res; 2020; 12():12811-12822. PubMed ID: 33364830
[TBL] [Abstract][Full Text] [Related]
8. Comparison of Four Albumin-Based Liver Reserve Models (ALBI/EZ-ALBI/PALBI/PAL) against MELD for Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization.
Ho SY; Liu PH; Hsu CY; Huang YH; Liao JI; Su CW; Hou MC; Huo TI
Cancers (Basel); 2023 Mar; 15(7):. PubMed ID: 37046586
[TBL] [Abstract][Full Text] [Related]
9. Modified CLIP score with the albumin-bilirubin grade retains prognostic value in HBV-related hepatocellular carcinoma patients treated with trans-catheter arterial chemoembolization therapy.
Cai XR; Chen ZH; Liu MM; Lin JX; Zhang XP; Chen J; Lin Q; Ma XK; Wen JY; Xie SD; Wu XY; Dong M
J Cancer; 2018; 9(13):2380-2388. PubMed ID: 30026834
[No Abstract] [Full Text] [Related]
10. Albumin-Based Liver Reserve Models vs. MELD 3.0 in Prognostic Prediction for Hepatocellular Carcinoma Patients with Renal Insufficiency.
Ho SY; Liu PH; Hsu CY; Tseng HT; Huang YH; Su CW; Hou MC; Huo TI
Int J Mol Sci; 2023 Nov; 24(23):. PubMed ID: 38069310
[TBL] [Abstract][Full Text] [Related]
11. Integration of albumin-bilirubin (ALBI) score into Barcelona Clinic Liver Cancer (BCLC) system for hepatocellular carcinoma.
Chan AW; Kumada T; Toyoda H; Tada T; Chong CC; Mo FK; Yeo W; Johnson PJ; Lai PB; Chan AT; To KF; Chan SL
J Gastroenterol Hepatol; 2016 Jul; 31(7):1300-6. PubMed ID: 26751608
[TBL] [Abstract][Full Text] [Related]
12. Preoperative platelet-albumin-bilirubin grades predict the prognosis of patients with hepatitis B virus-related hepatocellular carcinoma after liver resection: A retrospective study.
Luo HM; Zhao SZ; Li C; Chen LP
Medicine (Baltimore); 2018 Mar; 97(12):e0226. PubMed ID: 29561452
[TBL] [Abstract][Full Text] [Related]
13. Validation and ranking of seven staging systems of hepatocellular carcinoma.
Chen ZH; Hong YF; Lin J; Li X; Wu DH; Wen JY; Chen J; Ruan DY; Lin Q; Dong M; Wei L; Wang TT; Lin ZX; Ma XK; Wu XY; Xu R
Oncol Lett; 2017 Jul; 14(1):705-714. PubMed ID: 28693224
[TBL] [Abstract][Full Text] [Related]
14. Incorporating albumin-bilirubin grade into the cancer of the liver Italian program system for hepatocellular carcinoma.
Chan AW; Chong CC; Mo FK; Wong J; Yeo W; Johnson PJ; Yu S; Lai PB; Chan AT; To KF; Chan SL
J Gastroenterol Hepatol; 2017 Jan; 32(1):221-228. PubMed ID: 27257086
[TBL] [Abstract][Full Text] [Related]
15. Potential of PALBI-T score as a prognostic model for hepatocellular carcinoma in alcoholic liver disease.
Tanaka K; Tsuji K; Matsui T; Kang JH; Sakurai Y; Kodama Y; Minami R; Watanabe K; Katanuma A
JGH Open; 2022 Jan; 6(1):36-43. PubMed ID: 35071786
[TBL] [Abstract][Full Text] [Related]
16. Comparison of platelet-albumin-bilirubin (PALBI), albumin-bilirubin (ALBI), and child-pugh (CP) score for predicting of survival in advanced hcc patients receiving radiotherapy (RT).
Ho CHM; Chiang CL; Lee FAS; Choi HCW; Chan JCH; Yeung CSY; Huang JJ; Chan MKH; Blanck O; Wong FCS
Oncotarget; 2018 Jun; 9(48):28818-28829. PubMed ID: 29988960
[TBL] [Abstract][Full Text] [Related]
17. The model for end-stage liver disease based cancer staging systems are better prognostic models for hepatocellular carcinoma: a prospective sequential survey.
Huo TI; Lin HC; Hsia CY; Wu JC; Lee PC; Chi CW; Lee SD
Am J Gastroenterol; 2007 Sep; 102(9):1920-30. PubMed ID: 17573792
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of the albumin-bilirubin grade in patients with hepatocellular carcinoma and other liver diseases.
Feng D; Wang M; Hu J; Li S; Zhao S; Li H; Liu L
Ann Transl Med; 2020 Apr; 8(8):553. PubMed ID: 32411776
[TBL] [Abstract][Full Text] [Related]
19. Preoperative albumin-bilirubin grade combined with aspartate aminotransferase-to-platelet count ratio index predict outcomes of patients with hepatocellular carcinoma within Milan criteria after liver resection.
Luo H; Li C; Chen L
Biosci Trends; 2019 May; 13(2):176-181. PubMed ID: 31061272
[TBL] [Abstract][Full Text] [Related]
20. Liver Function Assessment Using Albumin-Bilirubin Grade for Patients with Very Early-Stage Hepatocellular Carcinoma Treated with Radiofrequency Ablation.
Oh IS; Sinn DH; Kang TW; Lee MW; Kang W; Gwak GY; Paik YH; Choi MS; Lee JH; Koh KC; Paik SW
Dig Dis Sci; 2017 Nov; 62(11):3235-3242. PubMed ID: 28983724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]